Centre for Drug Research and Development
Research and Commercialization Institute | |
Industry | Biotechnology |
Founded | 2007 |
Headquarters | Vancouver, British Columbia, Canada |
Key people |
Karimah Es Sabar, President and CEO Dr. Gregorio Aversa, Senior Vice President, Drug Development Kathryn Hayashi, CFO John Babcook, Vice President, Biologics Dr. Jason Crawford, Senior Director, Scientific Operations Doug Erfle, Director, Project Management Barry Gee, Director, Communications Dr. Dave Rogers, Director, Intellectual Property |
Number of employees | 95 |
Website |
The Centre for Drug Research and Development (CDRD) is Canada’s fully integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly funded health research and transform them into viable investment opportunities for the private sector – thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
CDRD Ventures Inc. (CVI) is the commercialization vehicle of The Centre for Drug Research and Development (CDRD), Canada’s national drug development and commercialization centre. With affiliations across more than 30 of Canada’s top research universities and institutes, CDRD is the only fully integrated centre of its kind in the country – and one of a handful in the world – with the full expertise and infrastructure to source, evaluate, and develop both small molecule and biologic innovative technologies in virtually any therapeutic area. And with a first right to negotiate for any of the technologies developed at CDRD (over 100 to date), CVI has a continuous and unparalleled pipeline of the most innovative and commercially promising pre-validated and thus de-risked technologies in Canada.
Divisions
- Target validation
- Screening
- Drug delivery
- Medicinal chemistry
- Pharmacology/toxicology
- Biologics
- External platforms
Funding
CDRD is supported by both public and private sector organizations looking to advance the successful commercialization of health research. These organizations include:
- The Canada Foundation for Innovation
- The Government of Canada's Networks of Centres of Excellence Program (which recognizes and supports CDRD as a Centre of Excellence in Commercialization in Research (CECR))
- The Province of British Columbia
- The Province of Alberta
- Michael Smith Foundation for Health Research
- Western Economic Diversification Canada
- Canadian Institute for Health Research
- Genome British Columbia
- Pfizer Inc.
- Johnson & Johnson
Participating institutions
CDRD currently has an existing portfolio of close to 80 supported research projects generated from its network of 20+ affiliated research institutions. These institutions represent Canada's top health research universities and research centres, as well as select international partner organizations. Collectively, these affiliated institutions invest several billion dollars in health-related research every year, and CDRD plays a pivotal role in translating that research into commercial products and economic returns including new jobs for British Columbia and Canada.
Key achievements
- 750 projects evaluated
- 99 novel technologies (135+ research projects) supported
- 125+ principal investigators assisted
- 80 technologies successfully advanced towards commercialization
- 8 technologies out-licensed to the private sector or being optioned by CVI
- 1 spin-off company launched
- 11 new patent families supported with CDRD data
- 18 collaborations on scientific publications
- $67 million in grant funding facilitated for PIs and their CDRD-related projects
- $30 million in international pharmaceutical sector investment attracted
- $152 million in incremental commercially focused health research being conducted as result of CDRD
- 94 postdoctoral fellows, co-op students and interns through the CDRD Training Program
- Over 75 drug development and commercialization workshops and seminars offered.